157 related articles for article (PubMed ID: 22300172)
1. Early metabolic markers that anticipate loss of insulin independence in type 1 diabetic islet allograft recipients.
Hirsch D; Odorico J; Danobeitia JS; Alejandro R; Rickels MR; Hanson M; Radke N; Baidal D; Hullett D; Naji A; Ricordi C; Kaufman D; Fernandez L
Am J Transplant; 2012 May; 12(5):1275-89. PubMed ID: 22300172
[TBL] [Abstract][Full Text] [Related]
2. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
[TBL] [Abstract][Full Text] [Related]
3. Early metabolic markers of islet allograft dysfunction.
Baidal DA; Faradji RN; Messinger S; Froud T; Monroy K; Ricordi C; Alejandro R
Transplantation; 2009 Mar; 87(5):689-97. PubMed ID: 19295313
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
[TBL] [Abstract][Full Text] [Related]
5. Long-term function (6 years) of islet allografts in type 1 diabetes.
Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
[TBL] [Abstract][Full Text] [Related]
6. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.
Teuscher AU; Kendall DM; Smets YF; Leone JP; Sutherland DE; Robertson RP
Diabetes; 1998 Mar; 47(3):324-30. PubMed ID: 9519735
[TBL] [Abstract][Full Text] [Related]
7. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.
Graham ML; Bellin MD; Papas KK; Hering BJ; Schuurman HJ
Xenotransplantation; 2011; 18(6):328-42. PubMed ID: 22168140
[TBL] [Abstract][Full Text] [Related]
8. Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants.
Bellin MD; Sutherland DE; Beilman GJ; Hong-McAtee I; Balamurugan AN; Hering BJ; Moran A
Transplantation; 2011 Feb; 91(3):367-72. PubMed ID: 21228753
[TBL] [Abstract][Full Text] [Related]
9. Insulin secretory patterns and blood glucose homeostasis after islet allotransplantation in IDDM patients: comparison with segmental- or whole-pancreas transplanted patients through a long term longitudinal study.
Secchi A; Taglietti MV; Socci C; Maffi P; Falqui L; Caldara R; Di Carlo V; Pozza G
J Mol Med (Berl); 1999 Jan; 77(1):133-9. PubMed ID: 9930948
[TBL] [Abstract][Full Text] [Related]
10. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
11. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
12. Primary graft function, metabolic control, and graft survival after islet transplantation.
Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
[TBL] [Abstract][Full Text] [Related]
13. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
[TBL] [Abstract][Full Text] [Related]
14. Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.
Soleimanpour SA; Hirshberg B; Bunnell DJ; Sumner AE; Ader M; Remaley AT; Rother KI; Rickels MR; Harlan DM
Cell Transplant; 2012; 21(6):1297-304. PubMed ID: 22080915
[TBL] [Abstract][Full Text] [Related]
15. Islet damage during isolation as assessed by miRNAs and the correlation of miRNA levels with posttransplantation outcome in islet autotransplantation.
Saravanan PB; Kanak MA; Chang CA; Darden C; Yoshimatsu G; Lawrence MC; Naziruddin B
Am J Transplant; 2018 Apr; 18(4):982-989. PubMed ID: 29210193
[TBL] [Abstract][Full Text] [Related]
16. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
[TBL] [Abstract][Full Text] [Related]
17. Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation.
Cretin N; Caulfield A; Fournier B; Bühler L; Becker C; Philippe J; Morel P
Transpl Int; 2001 Sep; 14(5):343-5. PubMed ID: 11692219
[TBL] [Abstract][Full Text] [Related]
18. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
Froud T; Faradji RN; Pileggi A; Messinger S; Baidal DA; Ponte GM; Cure PE; Monroy K; Mendez A; Selvaggi G; Ricordi C; Alejandro R
Transplantation; 2008 Jul; 86(1):36-45. PubMed ID: 18622276
[TBL] [Abstract][Full Text] [Related]
19. The Second Phase of Insulin Secretion in Nondiabetic Islet-Grafted Recipients Is Altered and Can Predict Graft Outcome.
Villard O; Brun JF; Bories L; Molinari N; Benhamou PY; Berney T; Wojtusciszyn A
J Clin Endocrinol Metab; 2018 Apr; 103(4):1310-1319. PubMed ID: 29319810
[TBL] [Abstract][Full Text] [Related]
20. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.
Keymeulen B; Gillard P; Mathieu C; Movahedi B; Maleux G; Delvaux G; Ysebaert D; Roep B; Vandemeulebroucke E; Marichal M; In 't Veld P; Bogdani M; Hendrieckx C; Gorus F; Ling Z; van Rood J; Pipeleers D
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17444-9. PubMed ID: 17090674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
